Novohope to showcase pet oral film supplements at Cannafest Prague 2026

Wuxi-based Novohope will present its oral dissolvable film and tablet pet supplements at Cannafest Prague from Nov. 6-8, 2026, targeting distributors, private-label brands and retail buyers. The appearance is part of the company’s push into Central and Eastern Europe as pet supplement makers look for easier-to-administer formats.

Why it matters: - Novohope is using Cannafest Prague 2026 to introduce a pet supplement format that aims to improve dosing convenience and compliance for dogs and cats. - The move puts a Wuxi-based pet nutrition brand in front of European trade buyers as the company tries to expand beyond current export markets. - Oral dissolvable films compete on administration, not just ingredient content, which could matter for owners whose pets refuse powders, tablets or chewables.

What happened: - Novohope is scheduled to exhibit at Cannafest Prague 2026 from Nov. 6-8 at the PVA Expo in Prague. - The company will present its orally disintegrating film and orally disintegrating tablet range to European distributors, private-label brand owners and retail buyers. - Novohope describes the Prague event as an entry point into Central and Eastern European markets. - The brand is based in Wuxi and operates in pet health supplements.

The details: - Novohope’s portfolio covers eye care and tear-stain management, coat and skin condition, digestive support, joint and mobility care, cardiovascular maintenance, weight management and calming. - The company’s products are sold in single-unit oral formats that dissolve in the mouth instead of being mixed into food. - The Prague display list includes seven stock-keeping units: EYES+, COAT+, BONE+, HEART+, PROBIO, CALM+ and FIT+. - EYES+ is an ODF at 2.1 g and is formulated for eye care and tear-stain management, with lutein and zeaxanthin listed among its ingredients. - COAT+ is an ODF at 2.5 g, with 10 films per pack, and is formulated for coat and skin condition with sodium hyaluronate, DHA and biotin. - BONE+ is an ODT at 2.1 g, with 10 pieces, and is formulated for joint and mobility support with glucosamine HCl 100 mg, hydrolysed collagen peptides 90 mg and undenatured type II collagen per unit. - HEART+ is an ODT at 2.1 g, with 10 pieces, and is formulated for cardiovascular maintenance with taurine 50 mg, L-carnitine 35 mg, coenzyme Q10 10 mg and vitamin E 5 IU. - PROBIO is an ODT at 2.5 g, with 10 pieces, and is formulated for digestive support with Bacillus coagulans at 1×10^9 CFU, pasteurised Akkermansia muciniphila at 12 mg, plus GOS and XOS. - CALM+ is an ODT at 2.5 g, with 10 films, and is formulated for calming support with α-casozepine 100 mg, L-theanine 50 mg and Pediococcus acidilactici CCFM6432 at 1×10^9 CFU. - FIT+ is an ODT in a 10-piece pack and is formulated for weight management. - The active content is fixed per film or tablet, which removes the measuring step required for powders mixed into food. - Each SKU is tied to a defined daily unit, so buyers have to match the range to an animal’s weight band and condition at the point of sale. - Novohope says its films dissolve within 10 seconds of contact with saliva and that active ingredients are absorbed through the oral mucosa rather than the gastrointestinal tract. - The company cites an absorption rate of up to 95% for the mucosal route, compared with about 35% for conventional supplement formats. - Those absorption figures are company-reported and have not been independently verified. - Third-party documentation referenced for the range is narrower and covers manufacturing registration, hazard communication data sheets and ingredient composition analyses for individual SKUs.

Between the lines: - The company is pitching convenience and compliance as the differentiator, while third-party evidence appears to support manufacturing and composition, not the claimed absorption advantage. - Central and Eastern Europe is typically used by Asian pet supplement suppliers for distributor discovery rather than direct consumer sales, so the Prague exhibition looks more like a channel-building event than a consumer launch. - Regulation remains market by market in Europe, and no EU-wide authorization is being claimed for the range. - Published market data points to a growing pet supplements category, but oral film remains a small part of it. - The National Animal Supplement Council quality seal remains a key trust marker in the U.S., suggesting manufacturing standards still matter more than format alone.

What's next: - Novohope will look to turn Prague trade meetings into distribution agreements in Central and Eastern Europe. - The company may seek additional market registrations after its U.S. facility registration and Chinese trademark filings. - Retail pricing will determine whether the film format stays a premium niche or moves closer to mainstream shelf space. - Novohope said it will continue developing pet health products and expand beyond current export markets, but it did not disclose financial targets or volume forecasts.

The bottom line: - Novohope is betting that a dissolving-film format can win buyers by making pet supplementation easier to give, not just by changing the ingredient list.